Regarding BCKA oxidation, direct evidence is still needed, such as measuring the BCKA oxidation metabolites to clarify how much BCKDK expression contributes to BCAA metabolism and, subsequently, breast cancer progression. This evidence concerns the gene ARID4B and breast carcinoma.